| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $842.6M | +12.5% |
| Cost of Revenue | $342.6M | +12.0% |
| R&D Expense | $218.6M | +23.0% |
| SG&A Expense | $106.7M | +22.1% |
| Operating Income | $51.0M | -17.1% |
| Pre-tax Income | $56.6M | +22.8% |
| Income Tax | $962K | +118.8% |
| Net Income | $18.1M | -64.7% |
| EPS (Basic) | $1.13 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $622.2M | -12.4% |
| Accounts Receivable | $124.3M | +17.8% |
| Inventory | $115.6M | +53.5% |
| Current Assets | $891.1M | -2.9% |
| Total Assets | $1.33B | +7.9% |
| Current Liabilities | $164.9M | +27.5% |
| Total Liabilities | $706.5M | +16.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $56.9M | -44.8% |
| Capital Expenditures | $28.6M | +158.9% |
| Investing Cash Flow | -$68.3M | -235.5% |
| Financing Cash Flow | -$76.3M | -120.4% |
| Free Cash Flow | $28.3M | -69.3% |
| +7.6% |
| EPS (Diluted) | $1.07 | +5.9% |
| Stockholders' Equity |
| $598.9M |
| -2.3% |